Eurobio Scientific Société anonyme (EPA: ALERS)
France
· Delayed Price · Currency is EUR 24.65
+0.05 (0.20%)
Aug 30, 2024, 5:39 PM CET
ALERS Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 7.13 | 7.13 | 11.35 | 13.86 | 5.64 | 8.82 | Upgrade
|
| Depreciation & Amortization | 8.15 | 8.15 | 14.31 | 12.03 | 9.38 | 8.19 | Upgrade
|
| Other Amortization | 7.52 | 7.52 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.74 | 0.74 | -3.89 | 0.01 | 0.18 | 0.17 | Upgrade
|
| Other Operating Activities | 1.9 | 1.9 | 8.84 | 9.51 | 4.04 | 2.4 | Upgrade
|
| Change in Other Net Operating Assets | -4.77 | -4.77 | -29.18 | -8.83 | -6.11 | -0.1 | Upgrade
|
| Operating Cash Flow | 20.67 | 20.67 | 1.43 | 26.58 | 13.12 | 19.47 | Upgrade
|
| Operating Cash Flow Growth | 1348.28% | 1348.28% | -94.63% | 102.51% | -32.61% | 61.21% | Upgrade
|
| Capital Expenditures | -25.55 | -25.55 | -29.45 | -20.11 | -12.38 | -11.28 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.24 | 0.24 | 8.75 | 1.89 | 0.07 | 0.33 | Upgrade
|
| Cash Acquisitions | -20.59 | -20.59 | -8.07 | -2.12 | -54.25 | -6.13 | Upgrade
|
| Investment in Securities | -0.25 | -0.25 | -0.57 | -8.3 | -0.58 | -0.07 | Upgrade
|
| Other Investing Activities | - | - | -0 | - | - | - | Upgrade
|
| Investing Cash Flow | -46.15 | -46.15 | -29.34 | -28.63 | -67.14 | -17.15 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 0.05 | Upgrade
|
| Long-Term Debt Issued | 50.67 | 50.67 | 15.21 | 38.29 | 57.09 | 9.3 | Upgrade
|
| Total Debt Issued | 50.67 | 50.67 | 15.21 | 38.29 | 57.09 | 9.35 | Upgrade
|
| Long-Term Debt Repaid | -21.92 | -21.92 | -18.77 | -18.08 | -3.87 | -5.01 | Upgrade
|
| Net Debt Issued (Repaid) | 28.75 | 28.75 | -3.56 | 20.21 | 53.22 | 4.34 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 35.58 | 24.59 | Upgrade
|
| Other Financing Activities | -7.06 | -7.06 | -4.33 | -2 | -4.05 | -0 | Upgrade
|
| Financing Cash Flow | 21.69 | 21.69 | -7.89 | 18.21 | 84.76 | 28.92 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.37 | -0.37 | 0.17 | 0.64 | -0.62 | 0.21 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - | - | Upgrade
|
| Net Cash Flow | -4.17 | -4.17 | -35.63 | 16.79 | 30.13 | 31.46 | Upgrade
|
| Free Cash Flow | -4.89 | -4.89 | -28.02 | 6.47 | 0.75 | 8.19 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 766.00% | -90.88% | 666.95% | Upgrade
|
| Free Cash Flow Margin | -2.37% | -2.37% | -14.42% | 3.89% | 0.58% | 7.27% | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -0.22 | -1.26 | 0.29 | 0.04 | 0.48 | Upgrade
|
| Cash Interest Paid | 3.9 | 3.9 | 2.93 | 2.21 | 1.4 | - | Upgrade
|
| Cash Income Tax Paid | 1.48 | 1.48 | -0.51 | -1.83 | -1.08 | 0.33 | Upgrade
|
| Levered Free Cash Flow | -14.85 | -14.85 | -34.69 | 3.62 | -9.67 | 7.32 | Upgrade
|
| Unlevered Free Cash Flow | -12.23 | -12.23 | -32.6 | 5.04 | -8.8 | 7.77 | Upgrade
|
| Change in Net Working Capital | 12.35 | 12.35 | 29.01 | 0.58 | 15.66 | -2.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.